ROQAF
Price
$0.02
Change
-$0.03 (-60.00%)
Updated
Jul 14 closing price
Capitalization
2.99M
RYTM
Price
$86.45
Change
-$0.82 (-0.94%)
Updated
Jul 25 closing price
Capitalization
5.7B
9 days until earnings call
Interact to see
Advertisement

ROQAF vs RYTM

Header iconROQAF vs RYTM Comparison
Open Charts ROQAF vs RYTMBanner chart's image
Roquefort Therapeutics
Price$0.02
Change-$0.03 (-60.00%)
Volume$1K
Capitalization2.99M
Rhythm Pharmaceuticals
Price$86.45
Change-$0.82 (-0.94%)
Volume$402.79K
Capitalization5.7B
ROQAF vs RYTM Comparison Chart in %
Loading...
ROQAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RYTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ROQAF vs. RYTM commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ROQAF is a Hold and RYTM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ROQAF: $0.02 vs. RYTM: $86.45)
Brand notoriety: ROQAF and RYTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ROQAF: 145% vs. RYTM: 54%
Market capitalization -- ROQAF: $2.99M vs. RYTM: $5.7B
ROQAF [@Biotechnology] is valued at $2.99M. RYTM’s [@Biotechnology] market capitalization is $5.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ROQAF’s FA Score shows that 1 FA rating(s) are green whileRYTM’s FA Score has 1 green FA rating(s).

  • ROQAF’s FA Score: 1 green, 4 red.
  • RYTM’s FA Score: 1 green, 4 red.
According to our system of comparison, RYTM is a better buy in the long-term than ROQAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ROQAF’s TA Score shows that 0 TA indicator(s) are bullish while RYTM’s TA Score has 5 bullish TA indicator(s).

  • ROQAF’s TA Score: 0 bullish, 4 bearish.
  • RYTM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RYTM is a better buy in the short-term than ROQAF.

Price Growth

ROQAF (@Biotechnology) experienced а 0.00% price change this week, while RYTM (@Biotechnology) price change was -3.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

RYTM is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RYTM($5.71B) has a higher market cap than ROQAF($2.99M). RYTM YTD gains are higher at: 54.430 vs. ROQAF (-57.300).
ROQAFRYTMROQAF / RYTM
Capitalization2.99M5.71B0%
EBITDAN/A-145.8M-
Gain YTD-57.30054.430-105%
P/E RatioN/AN/A-
RevenueN/A137M-
Total CashN/A314M-
Total DebtN/A4.06M-
FUNDAMENTALS RATINGS
RYTM: Fundamental Ratings
RYTM
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
23
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ROQAFRYTM
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
76%
Momentum
ODDS (%)
Bearish Trend 3 days ago
33%
Bearish Trend 3 days ago
75%
MACD
ODDS (%)
Bearish Trend 3 days ago
33%
Bearish Trend 3 days ago
79%
TrendWeek
ODDS (%)
N/A
Bearish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
20%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ROQAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RYTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GBIO4.610.41
+9.76%
Generation Bio Co
SVC3.030.14
+4.84%
Service Properties Trust
THG166.993.77
+2.31%
Hanover Insurance Group (The)
CMG46.761.02
+2.23%
Chipotle Mexican Grill
JMSB19.110.23
+1.22%
John Marshall Bancorp

ROQAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROQAF has been closely correlated with LYRA. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if ROQAF jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROQAF
1D Price
Change %
ROQAF100%
N/A
LYRA - ROQAF
85%
Closely correlated
-2.33%
EYPT - ROQAF
37%
Loosely correlated
-0.10%
RIGL - ROQAF
22%
Poorly correlated
-1.27%
RYTM - ROQAF
21%
Poorly correlated
-0.94%
OKYO - ROQAF
3%
Poorly correlated
-0.36%
More

RYTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, RYTM has been loosely correlated with CRNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if RYTM jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RYTM
1D Price
Change %
RYTM100%
-0.94%
CRNX - RYTM
46%
Loosely correlated
N/A
VRNA - RYTM
45%
Loosely correlated
+0.29%
RVMD - RYTM
43%
Loosely correlated
N/A
NRIX - RYTM
42%
Loosely correlated
-0.09%
IDYA - RYTM
42%
Loosely correlated
-1.33%
More